Two international teams of researchers have made significant gains in understanding the genetic basis of psoriasis, a chronic skin condition that can be debilitating in some patients. Their research, involving thousands of patients, is reported in two studies published this week in the advance online Nature Genetics.
Scientists at the University of Michigan have shown that gene therapy can be used to successfully stop the development of periodontal disease, the leading cause of tooth loss in adults.
Research finds one in 10 adults is being treated for arthritis pain.
Researchers at Hospital for Special Surgery have identified a potential new therapeutic target that could be used to treat inflammatory disorders, such as rheumatoid arthritis. Drugs that hit this new target are actually in trials for the treatment of another disease, leukemia.
CIHR Institute to support physical activity, mobility and health across the lifespan.
The American Academy of Orthopaedic Surgeons (AAOS) has approved and released an evidence-based clinical practice guideline on "The Treatment of Carpal Tunnel Syndrome."
The American College of Rheumatology Research and Education Foundation announced today that it has successfully raised more than $24 million for innovative rheumatoid arthritis research from the community-at-large and from the pharmaceutical and biotech industries.
Rheumatologists, dermatologists, and patient advocates have come together to publish the first-ever international guidelines for the treatment of psoriatic arthritis, a disease that mainly affects people who have psoriasis but also some people without it.
Age, sex and traditional risk factors"”such as hypertension, diabetes, smoking, and body mass"”are more important predictors of heart attack in patients with rheumatoid arthritis than the use of certain medications that have been considered the link between the two and lipid-lowering medications may actually reduce this risk, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.
The risk of cardiovascular disease in people with rheumatoid arthritis is just as high as the risk in people with type 2 diabetes, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.
Researchers provide new evidence to uncover why people with rheumatoid arthritis have an increased risk for heart failure, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.
Following a heart attack, people with rheumatoid arthritis suffer greater heart-related complications, including an increased risk for dying, when compared to other heart attack patients, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.
Future federally-mandated decreases in DXA reimbursement could lead to increased hip fractures among senior citizens, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.
Tossing your cigarettes may help control your rheumatoid arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.
Racial and ethnic disparities in systemic lupus erythematosus, and one of its worst complications, kidney failure, continue to grow in the U.S. The number of new cases of kidney failure due to lupus occurring among African Americans has now surpassed that in Caucasians, with a high proportion occurring among African American women, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.
After forty years of decline, rheumatoid arthritis may be on the rise in women, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.
Tai chi is effective in the treatment of pain and physical impairment in people with severe knee osteoarthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.
Patients taking glucocorticoids (e.g., prednisone) sometimes suffer from a common side effect of the treatment: osteoporosis. Now, though, these patients may have a new option to prevent bone loss and fractures, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.
Denosumab can increase bone mass in post menopausal women, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.
Patients who have not had successful treatment for their gout may find new hope in pegloticase, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.
Etanercept and methotrexate are shown to be safe and effective for long-term, continuous treatment of juvenile arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.
Therapies commonly used to treat rheumatoid arthritis do not seem to cause cancer, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.
Genes might explain why some patients with rheumatoid arthritis respond better to anti-TNF therapy than others, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.
A class of drugs known as syk kinase inhibitors appear to be effective in treating people with rheumatoid arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.
Anakinra may be effective in the treatment of an estimated 30,000 children with a certain form of juvenile arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.
Children with juvenile rheumatoid arthritis may miss fewer days of school when treated with abatacept, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.
The use of an antimalarial medication may prevent the development of diabetes in patients with rheumatoid arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.
When used in addition to other treatments, tadalafil is effective and well tolerated in the treatment of secondary Raynaud's phenomenon, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.
Both direct health care costs and costs associated with decreased work productivity are substantial for people with systemic lupus erythematosus, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.
Becoming pregnant when your lupus is clinically stable may be the key to fewer flares and a safer pregnancy, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.
The first study comparing two therapies, mycophenolate mofetil and intravenous cyclophosphamide, for the treatment of lupus nephritis in adolescents, shows that both appear safe and effective according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.
Early and aggressive treatment with a combination of an anti-TNF therapy and a disease modifying antirheumatic drug could put rheumatoid arthritis into remission, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.
Initial treatment with a combination of disease-modifying anti-rheumatic drugs may be effective in slowing the progression of rheumatoid arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.
People with rheumatoid arthritis may be at increased risk for periodontal disease, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.
A common, low-risk treatment, may prevent kidney damage in patients with lupus, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.
A clinical trial of a novel drug known as tanezumab has shown that treatment once every eight weeks significantly reduces pain in patients with knee osteoarthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.
Ayurvedic drugs may be safer, and just as effective, as glucosamine and celecoxib in treating patients with knee osteoarthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.
A person's risk of heart attack nearly doubles within the first ten years after being diagnosed with rheumatoid arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.
Below are highlights from the American College of Rheumatology 2008 Annual Scientific Meeting press conferences: Rheumatoid Arthritis Patients do Worse After a Heart Attack; Biomarkers Help Determine Most Effective Treatment for Muscle Tissue Inflammation; Insulin-Like Proteins Linked to Age-Related Bone Loss in Men and Women.
Being overweight, particularly if you have a higher than average body mass index, may increase your risk for developing severe osteoarthritis in your hips and knees, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.
Currently affecting 50 million adults in the United States, the pain and disability of arthritis frequently necessitates joint replacement surgery. As the number of Americans affected by arthritis is expected to increase, a new study finds relief for those who undergo the painful orthopedic procedures.
Free webinar....Join orthopaedic surgeons from across the country as they discuss the latest and greatest options and advancements your audience needs to know about when it comes to joint replacement...from the comfort of your own office!
Representative Patrick Kennedy (RI) introduced H.R. 7078, known as the Prevention, Awareness, and Research of Autoimmune Diseases Act of 2008, to Congress on September 25, 2008.
In a NEJM study, investigators concluded that arthroscopic surgery for osteoarthritis of the knee provides no additional benefit to optimized physical and medical therapy. In an accompanying editorial, however, Robert G. Marx, M.D., an orthopedic surgeon at Hospital for Special Surgery, points out that the study has some weaknesses and argues strongly that arthroscopy does have a role in some patients with osteoarthritis.
Hospitalizations for osteoarthritis soared from about 322,000 in 1993 to 735,000 in 2006.
Almost half of all U.S. adults and nearly two-thirds of obese adults will develop painful osteoarthritis of the knee by age 85, a study based at the University of North Carolina at Chapel Hill suggests.
New designs and innovations in total ankle replacements give patients increased mobility and better outcomes.
The American College of Rheumatology Research and Ed. Found. (ACR REF) has selected 15 experienced researchers from leading institutions to receive an estimated $6 million from the Foundation's Within Our Reach: Finding a Cure for Rheumatoid Arthritis campaign. The awards are the second round of grants funded by the $30 million national multi-year fundraising effort focused specifically on rheumatoid arthritis.
People coping with rheumatoid arthritis or lupus already have a lot to deal with. Even so, paying attention to heart health may be especially important for this group. The August 2008 issue of the Harvard Heart Letter reports that rheumatoid arthritis doubles a person's risk of heart attack or cardiac arrest. Heart disease risk is even higher with lupus, and a new study suggests that gout, another common kind of arthritis, is also linked to cardiovascular disease.
Now approaching retirement, many members of the "Me Generation" aren't ready to slow down, even if their bodies are. Foot and ankle surgeons say Baby Boomers are more likely than previous generations to seek care when arthritis develops in their toes, feet and ankles.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right